Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Rébillard

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|June 28, 2007
[Epidemiology of urogenital cancers in France]Xavier Rébillard, Brigitte Tretarre,
La Revue Du Praticien|March 17, 2004
[Surgery of prostate cancer]Arnauld Villers, Xavier Rébillard
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Information communication and personalized care program]Xavier Rébillard, Jean-Louis Davin
La Revue Du Praticien|March 17, 2004
[The epidemiology of prostate cancer]Xavier Rébillard, Brigitte Tretarre, Arnauld Villers
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Treatment by HIFU of prostate cancer: survey of literature and treatment indications]Xavier Rébillard, Jean-Louis Davin, Michel Soulié, et al.
World Journal of Urology|June 4, 2020
Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent dataPierre-Jean Lamy, Xavier Rébillard, Francis Vacherot, et al.
BMC Medical Research Methodology|July 29, 2015
Prostate cancer: net survival and cause-specific survival rates after multiple imputationAdeline Morisot, Faïza Bessaoud, Paul Landais, et al.
Presse Medicale (Paris, France : 1983)|October 17, 2017
[Rates of total and free PSA prescriptions in France (2012-2014)]Philippe Tuppin, Claire Leboucher, Gabrielle Peyre-Lanquar, et al.
Cancer Medicine|January 4, 2024
Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP studyMelissa Sawaya, Emilie Cordina-Duverger, Pierre-Jean Lamy, et al.
BMC Cancer|August 14, 2020
Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control studyNadine Houédé, Xavier Rébillard, Sophie Bouvet, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|June 28, 2007
[Epidemiology of urogenital cancers in France]Xavier Rébillard, Brigitte Tretarre,
La Revue Du Praticien|March 17, 2004
[Surgery of prostate cancer]Arnauld Villers, Xavier Rébillard
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 23, 2005
[Information communication and personalized care program]Xavier Rébillard, Jean-Louis Davin
La Revue Du Praticien|March 17, 2004
[The epidemiology of prostate cancer]Xavier Rébillard, Brigitte Tretarre, Arnauld Villers
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 6, 2004
[Treatment by HIFU of prostate cancer: survey of literature and treatment indications]Xavier Rébillard, Jean-Louis Davin, Michel Soulié, et al.
World Journal of Urology|June 4, 2020
Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent dataPierre-Jean Lamy, Xavier Rébillard, Francis Vacherot, et al.
BMC Medical Research Methodology|July 29, 2015
Prostate cancer: net survival and cause-specific survival rates after multiple imputationAdeline Morisot, Faïza Bessaoud, Paul Landais, et al.
Presse Medicale (Paris, France : 1983)|October 17, 2017
[Rates of total and free PSA prescriptions in France (2012-2014)]Philippe Tuppin, Claire Leboucher, Gabrielle Peyre-Lanquar, et al.
Cancer Medicine|January 4, 2024
Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP studyMelissa Sawaya, Emilie Cordina-Duverger, Pierre-Jean Lamy, et al.
BMC Cancer|August 14, 2020
Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control studyNadine Houédé, Xavier Rébillard, Sophie Bouvet, et al.
Pageof 3